This blend brings together two of the most widely studied research peptides in a single vial containing 10mg BPC-157 and 10mg TB-500
Mounjaro has been approved recently for both obesity and diabetes, with access initially limited to specialist clinics
Its flatter PK profile could also mean fewer gastrointestinal side effects , a common issue with current incretin therapies
The exact mechanism is not fully understood, but it may involve slowed gastric emptying and increased satiety through effects on central appetite centres in the brain
Belongs to a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists
It is also worth noting that these side effects can be exacerbated by other factors, such as stress, lack of sleep, or even the presence of underlying conditions that may not be directly related to the medication